Shiraz Haron-Khun

CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.

D. Freimark, S. Sperling, O. Binah, 2017, Heart rhythm.

The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia

B. Attali, M. Arad, A. Peretz, 2020, Frontiers in Pharmacology.

Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.

J. Seidman, E. Arbustini, D. Freimark, 2014, The Israel Medical Association journal : IMAJ.

SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias

B. Attali, J. Behar, M. Eldar, 2017, EMBO molecular medicine.

SK 4 K + channels are therapeutic targets for the treatment of cardiac arrhythmias

B. Attali, J. Behar, M. Eldar, 2017 .